Marshfield currently has a confidentiality agreement with Aspirus, which prevented many of the details of the potential project from being disclosed. However, Marshfield Clinic Health System CEO Dr. Susan Turneywrote in an email to the Marshfield News-Herald that the two parties are “in active discussions.”
Although there is no hard deadline for a final decision on the deal, Dr. Turney said she expects Marshfield to update its board this spring and discuss next steps in the near future.
Marshfield Executive Director Narayana Murali told the Marshfield News-Herald that adding the facility will ensure local specialist physicians have the technology they need to care for patients.
More articles on transactions and valuation issues:
Valeant Pharmaceuticals International to acquire Salix Pharmaceuticals
6 recent hospital transactions and partnerships
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
